ProPhase Labs Provides Update on Linebacker-1 Cancer Co-Therapy Program and Outlines Development Strategy
February 06, 2023 08:00 ET | ProPhase Labs, Inc.
Garden City, NY, Feb. 06, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a growth oriented and diversified diagnostics, genomics and biotech company, today provided an...
Standard Lithium Adds Claudia D'orazio and Anca Rusu to the Board, Expanding Project Management, Financial and Human Resources Expertise
January 17, 2023 06:00 ET | Standard Lithium
VANCOUVER, British Columbia, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial...
Figure 1.
Mayfair Gold Increases Fenn-Gib Open Pit Indicated Resource by 47% to 3.06M Ounces and Inferred Resource by 315% to 0.31M Ounces
October 18, 2022 08:00 ET | Mayfair Gold Corp.
Interim resource update includes assay results up to July 31, 2022, for approx. 67,000m drilled, or 61% of current drill programInfill and expansion drilling ongoing: approx. 96,000m completed to...
Warpath Update 5.0 Feature Image
Warpath’s “Brothers Unite” Community Tournament Kicks Off with a Content-Packed Update, Bringing the Mobile Title to Version 5.0
August 19, 2022 09:00 ET | Lilith Games
Call in the Cavalry, as New 5.0 Update Adds Swaths of New Content and New Gameplay Mechanics, Including Highly Requested FPS Mode SHANGHAI, China, Aug. 19, 2022 (GLOBE NEWSWIRE) -- It’s...
grapefruit LOGO.png
Grapefruit USA, Inc. Provides Update on Diagnostic Lab Corporation, Inc. Acquisition, Secures New Financing
August 18, 2022 06:00 ET | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
Compass Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 01, 2022 08:00 ET | Compass Therapeutics
Phase 2/3 trial of CTX-009 (DLL4 X VEGF-A bispecific) and paclitaxel in biliary tract cancer (BTC) anticipated to begin in the United States in Q3 2022A Phase 2 trial of CTX-009 as a monotherapy in...
Osisko Development Announces Tintic Project update
June 28, 2022 08:00 ET | Osisko Development Corp.
MONTREAL, June 28, 2022 (GLOBE NEWSWIRE) -- Osisko Development Corp. (“Osisko Development” or the “Company”) (ODV TSX.V & NYSE) is pleased to provide an update on the recently acquired Tintic...
Bar Chart
uniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
June 23, 2022 07:05 ET | uniQure Inc.
~ Treatment generally well-tolerated with no significant safety issues related to AMT-130 in treated patients through one year of follow-up ~ ~ A mean reduction of 53.8% of mutant HTT (mHTT) observed...
Osisko Announces Preliminary Q1 2022 Deliveries, Record Cash Margin and Provides Portfolio Update
April 12, 2022 17:00 ET | Osisko Gold Royalties Ltd.
MONTREAL, April 12, 2022 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) is pleased to provide an update on its first quarter 2022 deliveries,...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Announces New Milestones in Preparation of Dry Eye Disease Diagnostics Launch
February 15, 2022 09:00 ET | AXIM BIOTECHNOLOGIES, INC
AXIM is driven to positively transform the state of Dry Eye Disease (DED) testing and diagnosis The company will deploy industry leader IUL’s state-of-the-art iPeak readers Company Adds Veteran Lab...